BSN Capital Partners’s Synopsys SNPS Stock Holding History

BSN Capital Partners’s Portfolio SNPS Stock Details SNPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-61,000	Closed	-$20.2M	–	19
2022 Q4	$20.2M	Buy	+61,000	New	+$19.1M	1.43%	19

Other funds holding SNPS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

BSN Capital Partners's SNPS Position: Q1 2023 in Review

BSN Capital Partners sold out of Synopsys (SNPS) in Q1 2023, closing a stake of 61,000 shares — an estimated $20.2M sold.

BSN Capital Partners first reported a position in SNPS in Q4 2022 and held it in 1 quarter. The position peaked at $20.2M in Q4 2022. 934 funds tracked by Wall St. Rank hold SNPS as of Q1 2023.

BSN Capital Partners reported no remaining Synopsys position as of Q1 2023 after selling out during the quarter.
BSN Capital Partners sold 61,000 Synopsys shares in Q1 2023, an estimated $20.2M.
BSN Capital Partners first reported a position in Synopsys in Q4 2022 and held it in 1 quarter.
BSN Capital Partners's Synopsys position peaked at $20.2M in Q4 2022.
934 funds tracked by Wall St. Rank held Synopsys as of Q1 2023.

Based on BSN Capital Partners's 13F filing for Q1 2023, filed 20 Apr 2023.